Relatlimab
Relatlimab (BMS-986016) is a human monoclonal antibody anti-LAG-3 antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC50 value of 0.67 nM and LAG-3/FGL1 interaction with an IC50 value of 0.019 nM. Relatlimab can be used in research of cancer[1].
Product Specifications
CAS Number
[1673516-98-7]
Product Name Alternative
BMS-986016
UNSPSC
12352203
Target
LAG-3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/relatlimab.html
Purity
98.00
Solubility
10 mM in DMSO
Smiles
[Relatlimab]
Molecular Weight
(145.58 kDa)
References & Citations
[1]Thudium K, et, al. Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab. Cancer Immunol Res. 2022 Aug 18:CIR-22-0057.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7192683 Inquire
Rabbit anti-Gossypium hirsutum (Upland cotton)(Gossypium mexicanum) ATPH Polyclonal Antibody
Ask
View Details GTR15113395 1 Vial
Lentiviral human NECTIN1 shRNA (UAS) - Lentiviral human NECTIN1 shRNA (UAS) plasmid
Ask
View Details